Proteon Therapeutics, Inc. (PRTO)

[Jt0082]

Don't worry I remember your cautiousness in R-IT and how you missed the big move. :) But I will grant you that you totally called the total pessimism on the AMRN board a few months back and came in at a great time taking advantage of the sell off! That being said you should have been in it prior to the trial considering your own experience, JELIS and knowledge in the space.

On your points, I can understand you would have a view considering your previous loss in the first trial and this name. Did you sell or are you still holding? I think P values wont actually be marginal as trial now is over 600 patients almost double, so based on the stats plan we could be looking at <0.001 and <0.01 in patecty2. Also I think they even have a chance at hitting primary patency, although its not really relevant any more.... I agree with you they need BOTH secondary endpoints but these endpoints are really one and the same almost 90% correlation. Agree with you would be failure if don't hit both and or not going in same direction. But they did in patency1. All we need is the same result as before and its a win.